The National Health Surveillance Agency (ANVISA in Portuguese) approved four Collegiate Board Resolutions (RCC) related to the Brazilian Pharmacopeia (FB). The regulations were reviewed at the 8th Public Meeting of the Collegiate Board in 2026.